Statistics for Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Total visits
views | |
---|---|
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy | 105 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
File Visits
views | |
---|---|
40120_2021_Article_235.pdf | 30 |
java.util.UUID:3ea4b905-be71-467b-95c4-af85e9b41476 | 28 |
java.util.UUID:fea65c52-7b73-4e38-9387-393fbade5411 | 11 |
java.util.UUID:2516c9f5-e9a4-4dd4-a46e-636db748cbd3 | 10 |
Top country views
views | |
---|---|
United States | 72 |
India | 6 |
Bulgaria | 2 |
Japan | 2 |
South Korea | 2 |
China | 1 |
Malaysia | 1 |
Russia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 41 |
Washington | 9 |
Fairfield | 6 |
Mumbai | 5 |
Houston | 4 |
Hyattsville | 3 |
Lake Mary | 2 |
Sofia | 2 |
Ann Arbor | 1 |
Bartlesville | 1 |
Beijing | 1 |
Boston | 1 |
Cambridge | 1 |
Cheonan | 1 |
New York | 1 |
Pune | 1 |
Seoul | 1 |
Seremban | 1 |
Sundbyberg | 1 |
Yekaterinburg | 1 |